Case Name: Hazel JACKSON and Clarence Jackson v. JANSSEN PHARMACEUTICALS, INC.; Johnson & Johnson, Inc.; and Pervez Musarat, M.D.; Florida Parishes Human Services Authority; Rosenblum Mental Health Center, LLC; Ann Arretteig, M.D.; Sharon Hoffman, M.D.; and Greenbrier Hospital, LLC
Court: Louisiana Supreme Court
Jurisdiction: Louisiana
Decision Date: 2017-01-09
Citations: 208 So. 3d 881
Docket Number: No. 2016-CC-1767
Parties: Hazel JACKSON and Clarence Jackson v. JANSSEN PHARMACEUTICALS, INC.; Johnson & Johnson, Inc.; and Pervez Musarat, M.D.; Florida Parishes Human Services Authority; Rosenblum Mental Health Center, LLC; Ann Arretteig, M.D.; Sharon Hoffman, M.D.; and Greenbrier Hospital, LLC
Judges: JOHNSON, C.J., would grant and assigns reasons.
Reporter: Southern Reporter, Third Series
Volume: 208
Pages: 881–881

Head Matter:
Hazel JACKSON and Clarence Jackson v. JANSSEN PHARMACEUTICALS, INC.; Johnson & Johnson, Inc.; and Pervez Musarat, M.D.; Florida Parishes Human Services Authority; Rosenblum Mental Health Center, LLC; Ann Arretteig, M.D.; Sharon Hoffman, M.D.; and Greenbrier Hospital, LLC
No. 2016-CC-1767
Supreme Court of Louisiana.
01/09/2017
JOHNSON, C.J., would grant and assigns reasons.
HUGHES, J., would grant.
GENOVESE, J., would grant.

Opinion:
JOHNSON, Chief Justice,
would grant the writ application.
hi find the district court correctly denied defendants' motion for summary judgment in this case. I agree with the district court that a disputed issue of material fact exists concerning whether plaintiffs prescribing physicians were adequately warned of Risperdal's potential side effects, particularly in non-schizophrenic, elderly patients such as Ms. Jackson. Additionally, as plaintiffs effectively argue, the credibility of the prescribing physicians is clearly at issue in this case thereby rendering summary judgment premature.
Accordingly, I would grant the plaintiffs' writ application.